Study of Anlotinib After Lenvatinib in Patients With Hepatocellular Carcinoma

NCT04080154 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
28
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Zhongshan Hospital